Do you Qualify

Novartis is seeking people to participate in a clinical trial(s) testing the safety and effectiveness of Novartis products. Novartis recommends that you consult your doctor before participating in a clinical trial.

For more information about clinical trial participation, click here. Also, for additional information about how Novartis helps to protect the privacy of the personal information that you provide to us, please see the Novartis Privacy Policy.

Please review the details of the clinical trial(s) listed below and click on the one that you feel best suits your (or the participant's) condition.

Lung Cancer Study CASA404A2302 (ATTRACT 2)

The purpose of this study is to determine the effects of adding a Novartis investigational drug to a standard therapy in participants with advanced non-small cell lung cancer. An “investigational drug” is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA). This drug may not become commercially available in the United States for the treatment of lung cancer.